Drug recall D-0567-2023
Product
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.
Reason for recall
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Lots and codes
Lot# E220182, Exp. 12/31/2023
Recall details
- Recalling firm
- Camber Pharmaceuticals Inc., Piscataway, NJ
- Quantity
- 1568 bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 13, 2023
Related products
- Atovaquone – drug information
- NDC 31722-629 Atovaquone · Atovaquone 750 mg/5mL · Camber Pharmaceuticals, Inc.